EcoDrugPlus

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSSFOG00015004708
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSSFOG00015032382
Gene Symbol: AVPR1A
3 Cross references
145 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSSFOG00015025619
Gene Symbol: AVPR1A
3 Cross references
196 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSSFOG00015002009
Gene Symbol: AVPR2
3 Cross references
188 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSSFOG00015012643
Gene Symbol: AVPR2
3 Cross references
188 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 3-Like

Ensembl ID : ENSSFOG00015017270
Gene Symbol: LOC108924996
3 Cross references
210 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSSFOG00015017657
Gene Symbol: AURKA
1 Cross references
232 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSSFOG00015011498
Gene Symbol: AURKA
1 Cross references
232 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSSFOG00015018843
Gene Symbol: LOC108928590
3 Cross references
205 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSSFOG00015030261
Gene Symbol: LOC108925659
3 Cross references
160 Possible Orthologues:

Beta-1 Adrenergic Receptor-Like

Ensembl ID : ENSSFOG00015011100
Gene Symbol: LOC108929545
3 Cross references
196 Possible Orthologues:

Beta-2 Adrenergic Receptor

Ensembl ID : ENSSFOG00015017309
Gene Symbol: LOC108936872
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).